Evidence map›Paper›PMID 31412670›Full record

ArticleMedicina (Kaunas, Lithuania)2019

The Lipid Paradox Among Acute Ischemic Stroke Patients-A Retrospective Study of Outcomes and Complications.

Urvish Patel, Preeti Malik, Mihir Dave, Matthew S DeMasi, Abhishek Lunagariya, Vishal B Jani, Mandip S Dhamoon

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fatty Acids and Lipid Paradox-Neuroprotective Biomarkers in Ischemic Stroke.International journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Urvish PatelDepartment of Neurology, Creighton University School of Medicine, Omaha, NE 68124, USA. dr.urvish.patel@gmail.com.
Preeti MalikDepartment of Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mihir DaveDepartment of Internal Medicine, University of Nevada Reno School of Medicine, Reno, NV 89102, USA.
Matthew S DeMasiDepartment of Internal Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abhishek LunagariyaDepartment of Neurology, Creighton University School of Medicine, Omaha, NE 68124, USA.
Vishal B JaniDepartment of Neurology, Creighton University School of Medicine, Omaha, NE 68124, USA.
Mandip S DhamoonDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Creighton University · USIcahn School of Medicine at Mount Sinai · USAlbert Einstein College of Medicine · USUniversity of Nevada, Reno · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe Studies have suggested hypercholesterolemia is a risk factor for cerebrovascular disease. However, few of the studies with a small number of patients had tested the effect of hypercholesterolemia on the outcomes and complications among acute ischemic stroke (AIS) patients. We hypothesized that lipid disorders (LDs), though risk factors for AIS, were associated with better outcomes and fewer post-stroke complications. MATERIALS AND

methodWe performed a retrospective analysis of the Nationwide Inpatient Sample (years 2003-2014) in adult hospitalizations for AIS to determine the outcomes and complications associated with LDs, using ICD-9-CM codes. In 2014, we also aimed to estimate adjusted odds of AIS in patients with LDs compared to patients without LDs. The multivariable survey logistic regression models, weighted to account for sampling strategy, were fitted to evaluate relationship of LDs with AIS among 2014 hospitalizations, and outcomes and complications amongst AIS patients from2003-2014. RESULTS AND

conclusionsIn 2014, there were 28,212,820 (2.02% AIS and 5.50% LDs) hospitalizations. LDs patients had higher prevalence and odds of having AIS compared with non-LDs. Between 2003-2014, of the total 4,224,924 AIS hospitalizations, 451,645 (10.69%) had LDs. Patients with LDs had lower percentages and odds of mortality, risk of death, major/extreme disability, discharge to nursing facility, and complications including epilepsy, stroke-associated pneumonia, GI-bleeding and hemorrhagic-transformation compared to non-LDs. Although LDs are risk factors for AIS, concurrent LDs in AIS is not only associated with lower mortality and disability but also lower post-stroke complications and higher chance of discharge to home.

Indexed as

AgedBrain IschemiaFemaleHospitalizationHospital MortalityHumansInpatientsLipid Metabolism DisordersMalePatient DischargeRetrospective StudiesRisk FactorsStrokeSurveys and Questionnairesepilepsygastro-intestinal hemorrhagehemorrhagic transformationhyperlipidemianationwide inpatient sampleoutcomesStrokestroke associated pneumonia

Identifiers

PMID31412670
PMCPMC6723697
OpenAlexW2968864854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.